Jaffetilchin Investment Partners, LLC Mei Pharma, Inc. Transaction History

Jaffetilchin Investment Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 17, 2022	SELL	$2.33 - $3.37 $76,890 - $111,210	-33,000 Closed	0 $0
Q3 2021 Oct 25, 2021	SELL	$2.52 - $2.99 $83,160 - $98,670	-33,000 Reduced 50.0%	33,000 $91,000
Q2 2021 Aug 09, 2021	BUY	$2.6 - $3.65 $85,800 - $120,450	33,000 Added 100.0%	66,000 $181,000
Q4 2020 Feb 12, 2021	BUY	$2.6 - $3.32 $85,800 - $109,560	33,000 New	33,000 $87,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $333M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Jaffetilchin Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Jaffetilchin Investment Partners, LLC with notifications on news.